![](/img/cover-not-exists.png)
Immunogenicity and Safety of 2 Doses of an Investigational Herpes Zoster Subunit Vaccine Administered 2, 6 or 12 Months Apart in Adults 50 Years and Older: Results of a Phase III, Randomized, Open-Label, Multicenter Trial
Poder, Airi, Geeraerts, Brecht, Lal, Himal, Oostvogels, Lidia, Abeele, Carline Vanden, Heineman, Thomas C.Volume:
3
Language:
english
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofw172.616
Date:
December, 2016
File:
PDF, 318 KB
english, 2016